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S78Objective: The objective of our study was to report our hospital and long-term results after reinterventions on
the thoracic aorta.
Methods:Between 1986 and 2011, 224 reoperations on the proximal thoracic aorta after previous aortic surgery
were performed in our institution. The number of reinterventions quadrupled during the course of the study
period. Mean patient age was 58.1 years, and 174 patients (77.7%) were male. An urgent/emergency operation
was performed in 39 patients (17.4%). Indications for surgery included degenerative and chronic postdissection
aneurysm (n¼ 166), false aneurysm (n¼ 31), active prosthetic infection (n¼ 16), acute dissection (n¼ 10), and
other (n¼ 1). Surgical procedures involved the aortic root in 40.6% of patients, the ascending aorta in 9.4%, the
aortic arch in 24.6%, and the entire proximal thoracic aorta in 25.4%.
Results: Hospital mortality was 12.1%. On multivariate analysis, cardiopulmonary bypass time (odds ratio,
1.1023/minute; P<.001), and urgent/emergency status (odds ratio, 5.6; P<.001) emerged as independent pre-
dictors of hospital mortality. The follow-up was 98.7% complete. Estimated 1-, 5-, and 10-year survival rates
were 84.4%, 72.5%, and 48.5%, respectively. Eighteen reinterventions were performed during follow-up—16
because of the progression of aortic disease at the proximal aorta (n ¼ 2) and downstream aorta (n ¼ 14). Free-
dom from reoperation at 1, 5, and 10 years was 95.6%, 90.2%, and 81.5%, respectively.
Conclusions: Reoperative aortic surgery was associated with satisfactory short- and long-term results, espe-
cially if carried out on an elective basis. The extent of the aortic replacement did not impact survival and was
associated with a reduced need for reintervention. The progressive nature of aortic disease and the favorable
results of elective primary aortic interventions suggest favoring aggressive aortic resections at initial surgery.
(J Thorac Cardiovasc Surg 2013;S145:78-84)It has been estimated that the need for reoperative aortic sur-
gery will continuously increase and will eventually account
for 10% of all procedures on the ascending aorta.1 In the
literature, hospital mortality ranges from 8% to 15%,
which highlights the complexity of referred patients and
contemplated procedures in this setting.2-5 We report our
experience with 224 consecutive patients undergoing
reoperation on the thoracic aorta.METHODS
Medical records and available aortic data sets were reviewed to identify
patients who underwent reoperation on the thoracic aorta (after previous
aortic surgery) in our institution between January 1986 and September
2011. Patients who had previously undergone nonaortic surgery (eg, coro-
nary artery bypass grafting or mitral valve replacement) and those whoe Cardiac Surgery Department, Sant’Orsola-Malpighi Hospital, Bologna
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The Journal of Thoracic and Cardiovascular Surgrequired a reoperation only on the aortic valve were excluded from the
study. Thus, pre-, intra-, and postoperative variables were analyzed in
224 patients whose mean age was 58.1  13.3 years.
The distribution of the aortic reoperations throughout the study period is
shown in Figure 1. An urgent/emergency reoperation was performed in
17.4% of patients, and 8.9% of patients had already undergone at least 1
previous aortic redo procedure using a mid sternotomy. The mean time
elapsed from the last operation was 9.5  8.4 years. Patient demographics
and previous aortic procedures are reported in Tables 1 and 2. The indica-
tion for surgery was a degenerative aneurysm in 101 patients (45.1%),
a chronic postdissection aneurysm in 65 patients (29.0%), an acute type
A aortic dissection in 10 patients (4.5%), a false aneurysm in 31 patients
(13.8%), endocarditis in 16 patients (7.1%), and iatrogenic aortic supra-
valvular stenosis in 1 patient (0.4%).Surgical Techniques
A median sternotomy was used in 223 patients, and a median sternot-
omy with a left anterior thoracotomy (to obtain better exposure of the prox-
imal descending thoracic aorta) was used in 1 patient. For cardiopulmonary
bypass (CPB), a central arterial cannulation site (ascending aorta, aortic
arch, right axillary, innominate or carotid arteries) allowing antegrade
blood flow through the thoracoabdominal aorta was used in 119 patients
(53.2%), the femoral artery was cannulated in 104 patients (46.4%), and
right axillaryþ femoral artery cannulation was performed in the 1 remain-
ing patient (0.4%). Venous drainage was obtained by means of right
atrium, bicaval, or femoral cannulation, as indicated. The right superior
pulmonary vein, the pulmonary artery trunk, or the left ventricular apex
(with a left anterior minithoracotomy) was cannulated for left ventricular
drainage. Myocardial protection was obtained by means of antegrade
(n ¼ 207, 92.4%), retrograde (n ¼ 13, 5.8%), or retrograde þ antegrade
(n ¼ 2, 0.9%) intermittent infusion of cold crystalloid cardioplegia.ery c March 2013
Di Bartolomeo et al Panel 2Abbreviations and Acronyms
ASCP ¼ antegrade selective cerebral perfusion
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
OR ¼ odds ratioOn preoperative imaging tests, 26 patients presented with a sternum-to-
aorta distance of<1 cm. Of these patients, 18 were placed on CPB before
chest reopening, and 8 required deep hypothermic circulatory arrest. In 3
of the latter patients, brain perfusion was continued by cannulating the right
axillary artery and by isolating and clamping the innominate artery (proximal
to the origin of the right carotid artery) at the jugular notch before resternot-
omy. In all patients requiring various degrees of aortic arch replacement, or in
those undergoing chest reopening under circulatory arrest, brain protection
was achieved by means of antegrade selective cerebral perfusion (ASCP).
Our ASCP technique has been described previously. Briefly, it involves bilat-
eral brain perfusion,moderate hypothermia (26C), and a flow rate of 10 to 15
mmHg adjusted to maintaining a perfusion pressure between 40 and 70 mm
Hg.6 The CPB data are reported in Table 3.
Various aortic procedures were performed according to the underlying
pathology. Reoperative surgery involved 91 procedures (40.6%) on the
aortic root, 21 procedures (9.4%) on the ascending aorta, and 55 proce-
dures (24.6%) on the aortic arch. Concomitant procedures on the root, as-
cending aorta, and arch were performed in another 57 patients (25.4%),
and associated cardiac procedures in 29 patients (12.9%; Table 4). Root re-
placement was performed using a composite graft according to modified
Bentall or Cabrol techniques.7,8 For complete arch replacement, the arch
vessels were reimplanted using the en bloc or separated graft technique.9
In patients with a diseased descending thoracic aorta, conventional and fro-
zen elephant trunk10 techniques were frequently associated.
Careful debridementwith resectionof all the infected tissuewasperformed
in patients with active endocarditis; the left ventricular outflow tract was re-
constructed with a pericardial patch as indicated, and mechanical or biologic
graftswere used to replace the diseased aorta (homograft, n¼ 9; Toronto root,
n ¼ 1; shell-high conduit, n ¼ 4, mechanical composite graft, n ¼ 2).
Statistical Analysis
Continuous variables are expressed as the mean  1 SD and were ana-
lyzed by using the unpaired, 2-tailed t test. Categoric variables are pre-
sented as percentages and were analyzed with the c2 test or the Fisher
exact test when appropriate. A two-tailed P value<.05 was considered sta-
tistically significant. All the pre- or intraoperative variables that achieved
a P value<.05 in the univariate analysis were examined using multivariate
analysis by stepwise logistic regression to evaluate independent risk factors
for hospital mortality.
The patients were monitored in the outpatient clinic with computed to-
mography and magnetic resonance imaging, and by means of telephone
calls. Survival curves (taking into account perioperative deaths) and free-
dom from aortic reoperation (in the surviving patients) were estimated at
1, 3, 5, and 10 years using the Kaplan-Meier method. Independent predic-
tors of 10-year survival were determined using Cox proportional hazards




Overall, hospital mortality was 12.1% (n ¼ 27): 7.6%
(14/185) in elective patients and 33.3% (13/39) in urgent/The Journal of Thoracic and Caremergency patients (P < .001). Causes of death were
cardiac (n ¼ 6), neurologic (n ¼ 3), multiorgan failure
(n ¼ 15), sepsis (n ¼ 2), and intestinal ischemia (n ¼ 1).
Hospital mortality varied according to the underlying
pathology—4% in patients with degenerative aneurysms,
13.8% in patients with chronic dissections, 16.1% in pa-
tients with false aneurysms, 31.2% in patients with endo-
carditis, and 40.0% in patients with acute dissection
(P ¼ .001).
On multivariate analysis, urgency/emergency (odds ratio
[OR], 5.6; P<.001; 95% CI, 2.021-15.747) and CPB time
(OR, 1.023; P<.001; 95% CI, 1.012-1.036) were identified
as independent predictors of hospital mortality.
The main postoperative complications included stroke
(n ¼ 7, 3.1%), coma (n ¼ 4, 1.8%), ventilatory
support> 72 hours (n ¼ 28, 12.5%), temporary (n ¼ 12,
5.4%) and permanent (n¼ 2, 0.9%) dialysis, and bleeding re-
quiring rethoracotomy (n¼ 26, 11.6%). The mean intensive
care unit stay (standard error) was 6.1 0.7 days (Table 5).
Follow-up
Follow-up was 98.7% complete at a mean of 55.5  52.2
months (range, 0.13-221.7 months). Forty-nine patients died
during follow-up, and causes of death were cardiac related
in 7 patients, aortic rupture in 7, stroke/coma in 2, endocarditis
in 2, gut ischemia in 1, sepsis in 1, and noncardiac/aortic re-
lated in 29 patients (vehicular crash, n ¼ 1; neoplasm,
n ¼ 6; pneumonia, n ¼ 1; unknown, n ¼ 21). Kaplan-Meier
estimates of survival at 1, 3, 5, and 10 years were
84.4  2.5%, 79.0  2.9%, 72.5  3.4%, and
48.5  5.2%, respectively (Figure 2). On Cox regression,
age (OR, 1.074; P<.001; 95% CI, 1.039-1.109) and chronic
obstructive pulmonary disease (OR, 2.6; P ¼ .015; 95% CI,
1.208-5.607) emerged as independent predictors of reduced
long-term survival for patients surviving their most recent
reoperation.
Eighteen patients underwent subsequent aortic proce-
dures during follow-up. Of these, 3 patients underwent dif-
ferent degrees of open arch replacement (hemiarch
replacement, n¼ 1; total arch replacement, n¼ 2) as a result
of infective false aneurysm formation, aneurysmal progres-
sion of the aortic disease, and penetrating aortic ulcer,
whereas 15 patients underwent secondary endovascular
repairs using conventional (n ¼ 7) or frozen (n ¼ 7) trunks
as proximal landing zones because of the progressive dila-
tation of a chronically dissected descending thoracic aorta
(n ¼ 14) and a distal type 2 frozen elephant trunk endoleak
(n ¼ 1). Two patients died after secondary endovascular
procedures: one from abdominal aortic rupture and the
other from an aortoesophageal fistula. Freedom from aortic
redo at 1, 3, 5, and 10 years was 95.6 1.5%, 94.2 1.8%,
90.2  2.6%, and 81.5  5.2%, respectively (Figure 3).
Multivariate analysis failed to identify any independent
predictors of reintervention at follow up.diovascular Surgery c Volume 145, Number 3S S79
FIGURE 1. Distribution of aortic reoperations throughout the study
period.
TABLE 1. Patient demographics (n ¼ 224)
Variable Frequency %
Male 174 77.7
Age 58.1  13.3






Renal insufficiency 12 5.4
Peripheral vasculopathy 9 4.0
Cerebral vasculopathy 4 1.8
CAD 23 10.3
Marfan 13 5.8
Urgent/emergency status 39 17.4
Redo>2 20 8.9
Years from last operation 9.5  8.4
NYHA, New York Heart Association; COPD, chronic obstructive pulmonary disease;
CAD, coronary artery disease.
TABLE 2. Previous aortic procedures (n ¼ 224)
Variable Frequency %
Aortic valve replacement 93 41.5
Aortic valve þ ascending aorta replacement 9 4.0
Aortic valve replacement þ ascending aorta reduction 7 3.1
Aortic valve repair þ ascending aorta replacement 7 3.1
Aortic valve repair þ ascending aorta reduction 1 0.4
Aortic valve repair þ hemiarch replacement 1 0.4
Aortic valve repair þ ascending aorta replacement þ 1 0.4
Panel 2 Di Bartolomeo et alDISCUSSION
Although percutaneous aortic procedures have became
available to treat pseudo-aneurysms in high-risk patients
with favorable anatomic characteristics,11 the number of
reoperations on the thoracic aorta is increasing rapidly as
a result of the increased incidence of aortic diseases in an
aging population, the increased use of biologic aortic valves
and root substitutes, and the increased use of techniques for
valve-sparing aortic root reconstruction. Our experience
strongly confirms such a trend, because the number of aortic
reinterventions has quadrupled from the early 1990s to date
(Figure 1).
Aneurysmal and dissecting progression of aortic disease
and mechanical (noninfective pseudo-aneurysm, prosthetic
valve dysfunction/degeneration) or infective aortic compli-
cations represent the main indications for reoperative aortic
surgery. Schepens and colleagues12 have reported thatFIGURE 2. Kaplan-Meier estimate of 10-year survival.
S80 The Journal of Thoracic and Cardiovascular Surganeurysm formation and acute dissection accounted for ap-
proximately 50% of all indications for aortic reoperation in
a series of 124 patients. In our study population, the role of
the progression of aortic disease seems even moreaortic arch stent
Aortic valve commissurotomy 1 0.4
Bentall 37 16.5
David 2 0.9
Ascending aorta replacement 48 21.4
Ascending aorta reduction 2 0.9
Hemiarch replacement 4 1.8
Ascending þ hemiarch replacement 2 0.9
Ascending þ arch replacement 2 0.9
Ascending aorta replacement þ aortic arch stent 1 0.4
Ascending þ arch replacement þ elephant trunk 1 0.4
Ascending þ arch replacement þ frozen elephant trunk 1 0.4
Bentall þ hemiarch replacement 2 0.9
David þ arch replacement þ elephant trunk 1 0.4
David þ hemiarch replacement 1 0.4
Associated procedures
CABG 12 5.3
Mitral valve repair 8 3.6
Mitral valve replacement 1 0.4
Atrial septal defect closure 1 0.4
CABG, Coronary artery bypass grafting.
ery c March 2013








Antegrade þ retrograde 2 0.9
CPB time 202.5  75.2
Clamp time 140.2  52.4
Antegrade selective cerebral perfusion 112 50.0
ASCP time 77.2  42.4
Sternotomy on CPB 18 8.0
Sternotomy on HCA 8 3.6
CPB, Cardiopulmonary bypass; ASCP, antegrade selective cerebral perfusion;
HCA, hypothermic circulatory arrest.
TABLE 4. Surgical procedures (n ¼ 224)
Variable Frequency %
Root surgery 91 40.6
Bentall 67 29.9
Cabrol 1 0.4
Noncoronary sinus þ ascending aorta replacement 1 0.4
Aortic valve prosthesis-sparing operation 15 6.7
Aortic valve þ ascending aorta replacement 6 2.7
Aortic valve replacement þ pseudo-aneurysm direct
closure
1 0.4
Ascending aorta surgery 21 9.4
Ascending aorta replacement 19 8.5
Pseudo-aneurysm direct closure 1 0.4
Other 1 0.4
Arch surgery 55 24.6
Hemiarch replacement 11 4.9
Total arch replacement 13 5.8
Total arch replacement þ frozen elephant trunk 20 8.9
Total arch replacement þ elephant trunk 10 4.5
Total arch replacement þ descending aorta
replacement
1 0.4
Root þ ascending aorta þ arch surgery 57 25.4
Bentall þ hemiarch replacement 13 5.8
Bentall þ ascending and arch replacement 19 8.5
Bentall þ ascending and arch replacement þ frozen
elephant trunk
6 2.7
Bentallþ ascending and arch replacementþ elephant
trunk
5 2.2
Aortic valve prosthesis-sparing operation þ hemiarch
replacement
4 1.8
Aortic valveþ ascending aortaþ arch replacement þ
frozen elephant trunk
6 2.7
Aortic valve þ ascending aorta þ arch replacement 3 1.3
Aortic valve þ hemiarch replacement 1 0.4
Associated procedures
CABG 18 8.0
CABG þ mitral valve plasty 1 0.4
Mitral valve replacement 6 2.7
Tricuspid valve plasty 3 1.3
Ventricular septal defect closure 1 0.4
CABG, Coronary artery bypass grafting.
Di Bartolomeo et al Panel 2predominant, representing 80% of the indications for sur-
gery. Considering that failure to resect all diseased aortic
tissue at initial surgery increases the probability of subse-
quent surgery, and the excellent current outcomes after elec-
tive root/ascending aorta replacement, these observations
reasonably support a more aggressivemanagement of aortic
disease at the first operation, especially in low-risk younger
patients with or without connective tissue disorders. A fur-
ther clinical implication is that close and continual surveil-
lance with imaging techniques is mandatory in patients
undergoing aortic valve replacement or procedures on the
proximal thoracic aorta.
In the literature, hospital mortality after aortic reopera-
tions ranges from 8% to 15%.2-5 For the most part,
underlying disease, type of previous procedure, and
appropriate surgical techniques influence patient outcome.
In reoperative aortic surgery, probably more than in other
aortic/cardiac procedures, a valid strategy increases the
chances of a successful operation. Technically, the main
concerns include chest reentry, CPB institution,
myocardial/brain protection, and the specific technique of
aortic repair, the latter depending on the underlying
pathology. Reading the report of the previous surgical
intervention is of primary importance and can reduce the
proportion of unforeseeable events that are always
a possibility. Preoperative imaging and, in particular, an
angiographic computed tomographic scan, is mandatory
in every patient to perform a safe resternotomy; this will
assess the relationship existing between the aorta, the
aneurysm or conduit, and the undersurface of the sternum
(Figure 4). If sternal reopening is judged safe, our resternot-
omy techniques involve removal of the sternal wires, an
oscillating saw, patient arterial pressure< 100 mm Hg,
opening of the pleural spaces, and tubing for prompt CPB
institution ready on the operative table. Conversely, under
high-risk conditions—such as those of patients with aneu-
rysms in close contact with the sternum or with an aorta-The Journal of Thoracic and Carto-sternum distance of< 10 mm—sternal reopening can
be performedmore safely using a short period of CPB or un-
der deep hypothermic circulatory arrest. With this strategy,
difficult resternotomy does not emerge as an independent
predictor of mortality in this, or in the previous13 series
from our institution. Recently, in patients with pseudo-
aneurysms in contact with the sternum, we have avoided
deep hypothermia and circulatory arrest by cannulating
the axillary artery for CPB inflow, and—by isolating and
clamping the innominate artery at the jugular notch proxi-
mal to the origin of the carotid artery—we have been able
to institute brain perfusion before resternotomy. Another
similarly effective option would be to cannulate the right
(left) carotid artery to institute antegrade brain perfusion
before chest reopening.14diovascular Surgery c Volume 145, Number 3S S81
TABLE 5. Hospital outcomes
Variable Frequency %
Hospital mortality 27 12.1
Ventilatory support>72 h 28 12.5
Acute myocardial infarction 10 4.5
Renal complications 24 10.7
Temporary dialysis 12 5.4
Permanent dialysis 2 0.9





ICU stay, mean days  SE 6.1  0.7
ICU, Intensive care unit; SE, standard error.
Panel 2 Di Bartolomeo et alVessel selection for arterial cannulation depends on the
presence of aortic dissection, atheromatous disease, the
extent of the aortic replacement, and the degree of safety
at chest reentry. In general, when surgery is limited to the
root/ascending aorta and a low-risk resternotomy is antici-
pated, CPB arterial inflow can be obtained by cannulating
the distal ascending aorta or the aortic arch. In patients
who require some extent of aortic arch replacement, the
right axillary artery or the innominate artery represent our
favorite sites for arterial cannulation, mainly because they
facilitate antegrade cerebral perfusion. In our institution,
the femoral artery is cannulated in patients who require
CPB before resternotomy when other central sites are un-
available for cannulation. However, it should be noted
that, in a recent series of aortic reoperations, we could not
show any benefit in terms of survival or reduction of stroke
in patients undergoing central arterial cannulation com-
pared with those having cannulation of the femoral artery.13
To guarantee the safety of the procedure, great attention
also has to be paid to myocardial protection. In patients withFIGURE 3. Kaplan Meier estimate of 10-year freedom from reoperation.
S82 The Journal of Thoracic and Cardiovascular Surgmoderate to severe aortic regurgitation, avoiding (or delay-
ing) ventricular fibrillation—and consequently left ventri-
cle distension—will reduce the risk of myocardial
dysfunction at the end of the operation. In patients in
whom the ascending aorta (or graft) cannot be controlled
and clamped rapidly, transapical venting of the left ventricle
through a small left thoracotomy should be considered.
After clamping (or under circulatory arrest), routes for
cardioplegia infusion may vary according to patient charac-
teristics. Antegrade cardioplegia infusion through the
ascending aorta should be avoided in patients with aortic
valve/prosthesis insufficiency and in the presence of proxi-
mal leaks from dehiscent suture lines. Selective cannulation
of the coronary ostia should be carried out with care if
detachment, dissection, or infection of the ostia have been
documented previously. Retrograde or percutaneous infu-
sion of cardioplegia15 through the coronary sinus may rep-
resent a valid alternative. If difficulties in delivering
cardioplegia are anticipated with all routes, a lower core
temperature will provide some extra time for myocardial
protection to address the complex situation more effec-
tively. In our experience, we were able to protect the heart
with antegrade infusion of cardioplegia in approximately
90% of cases, with a postoperative incidence of myocardial
infarction of 4.5%, which we consider satisfactory.
Approximately 50% of our aortic reoperations involved
some degree of arch replacement. Undoubtedly, brain pro-
tection plays an important role in this setting, and ASCP,
by avoiding deep hypothermia and providing a safe period
of brain protection (up to at least 90 minutes),6 has repre-
sented our method of choice since 1996. In this series, the
mean ASCP time was 77 minutes and our stroke/coma
rate was 4.9%. We strongly believe our results would
have been far worse if we had used different methods of
brain protection.
In the context of a repeat Bentall procedure, the reattach-
ment of the coronary ostia is of paramount importance
because torsion and kinking resulting from inadequate mo-
bilization are more likely than in primary interventions. The
modified button Bentall technique remains the one we
always aim for, even though difficult mobilization of the
coronary arteries and large aneurysms may hinder a safe
and tension-free conduit-to-coronary anastomosis. In this
setting, compared with a straight tube graft, the Valsalva
composite graft, which mimics aortic sinuses, may help in
performing a tension-free coronary artery reattachment by
reducing the distance between the coronary ostia and the
graft itself. However, in some cases, the Cabrol technique
has a pivotal role, often as a bailout procedure, given that
long-term outcomes may be disappointing as a result of
the high rate of Cabrol graft thrombosis and occlusion.16,17
In patients who underwent aortic valve replacement during
prior interventions and who require a root replacement,
a prosthesis-sparing operation may facilitate surgery andery c March 2013
FIGURE 4. Preoperative angiographic computed tomographic scan showing a likely safe chest reentrywith an aorta-to-sternumdistance>10mm(A), a high-
risk resternotomy resulting from aortic pseudo-aneurysm sternal erosion (B), and a patent left internal thoracic artery graft in contact with the undersurface of
the sternum (C).
Di Bartolomeo et al Panel 2may likely reduce the risk of pseudo-aneurysm formation.18
This procedure foresees the replacement of the aortic root
with a graft sutured directly to the well-functioning valve
prosthesis. So far, 14 such procedures have been performed
in our institution without mortality (and major complica-
tions), confirming preliminary favorable outcomes from
other centers.19
In the current series, overall hospital mortality was
12.1%: 7.6% in the elective patients and 33.3% in the
urgent/emergency patients. Undoubtedly, the underlying
pathology greatly influenced hospital outcomes, as demon-
strated by higher mortality rates in patients with active en-
docarditis and acute dissection, and with urgent/emergency
status, which was as the most relevant predictor for hospital
mortality using multivariate analysis (OR, 5.6). Once more,
CPB time was confirmed to be the strongest intraoperative
predictor of mortality (bearing in mind that extent of aortic
replacement was not), and likely acted as a surrogate for
complex aortic procedures, such as those required for
redo root or arch operations in patients with acute dissection
and active endocarditis. It remains true that aortic reopera-
tion for active endocarditis, at least in our hands, still repre-
sents a serious concern and, with the lack of randomized
studies comparing outcomes after medical or surgical man-
agement, selecting the most effective (or least harmful)
therapy continues to be difficult in this setting.
Nevertheless, we believe that our results are satisfactory
after considering that approximately 50% of our patients
underwent some degree of arch replacement (mostly total)
and approximately 25% had complete replacement of the
proximal thoracic aorta from the aortic valve to the isthmus.
Despite this, confirming previous data,13 the extent of aortic
replacement was not a predictor of mortality, indicating
(albeit with some exceptions) that aggressive aorticThe Journal of Thoracic and Carresections should always be performed. Our long-term
data continue to support this concept. Fourteen of 18 reop-
erations at follow-up were endovascular, and were indicated
for treating chronic postdissection aneurysms of the down-
stream aorta, which could not have been addressed during
the earlier intervention through a sternotomy; 2 of 3 open
surgical reoperations were necessary because of progres-
sion of the disease at the proximal aorta (aneurysm forma-
tion and penetrating ulcer).CONCLUSIONS
Aortic reoperative surgery is being performed increas-
ingly and represents a formidable challenge for the
cardiovascular surgeon. Appropriate surgical strategies,
techniques, and methods for organ protection are crucial
in obtaining favorable postoperative outcomes.
In our experience with 224 thoracic aorta reoperations,
short- and long-term results were excellent in patients
with aneurysms, and disappointing in those who presented
with acute dissection and active endocarditis. Urgent/emer-
gency surgery and prolonged duration of CPB emerged as
strong predictors of reduced hospital survival; extensive
aortic replacement did not increase hospital mortality and
resulted in a reduced need for reintervention in the proximal
aorta. The well-known progressive nature of aortic disease
and the favorable results of elective primary aortic interven-
tions would suggest that diseased aortic tissue should be
resected aggressively during the initial surgery.References
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